Table 4.
Summary of characteristics of patients showing clinical response
| Patient # | Gender/Age | Stage | Prior treatment | Best Response1 | Duration (months) |
|---|---|---|---|---|---|
| # 093-020 | Male/60 y | M1a | Surgery | CR | 30 |
| # 095-050 | Female/70 y | IIIc | Surgery-ILP | PR | 33+ |
| # 095-200 | Male/46 y | M1a | Surgery/Interferon | PR | 35+ |
| # 095-020 | Female/44 y | M1b | Surgery-ILP | SD/NED | 30+ |
| # 095-060 | Female/69 y | M1b | Surgery | SD/NED | 22+ |
| # 093-170 | Female/84 y | M1a | Surgery | SD | 13 |
| # 095-080 | Male/55 y | M1a | Surgery-Biotherapy | SD | 10 |
| # 095-190 | Female/54 y | M1a | Surgery/Cilengitide | SD | 10 |
| # 096-020 | Female/58 y | M1b | Surgery-RT-Chemo-Biotherapy | SD | 5 |
Abbreviations: RT: radiotherapy; ILP: isolated limb perfusion; CR: complete response; PR: partial response; SD: stable disease; NED: no evidence of disease.